“…Forty-two studies focused on major depressive disorder or depressive symptoms (Acarturk et al, 2018, 2021; Ahmad et al, 2021; Böge et al, 2020; Borho et al, 2020; Braun-Lewensohn et al, 2019; Cheung Chung et al, 2018; Chung & Shakra, 2022; Chung et al, 2017, 2021; Chung, AlQarni et al, 2018; Chung, Shakra et al, 2018; Demir et al, 2020; Euteneuer & Schäfer, 2018; Fuhr et al, 2019; Gammouh et al, 2015; Georgiadou et al, 2018, 2020; Javanbakht et al, 2019; Mahmood et al, 2019; Marwa, 2016; McGrath et al, 2020; Mohammad et al, 2018; M’zah et al, 2019; Naal et al, 2021; Naja et al, 2016; Oda et al, 2021; Okenwa-Emegwa et al, 2019; Poole et al, 2018; Rizkalla & Segal, 2018, 2019; Röhr et al, 2020; Schlechter et al, 2021; Sengoelge et al, 2019; Sevinc et al, 2021; Sim et al, 2018; Stevenson et al, 2019; Tekeli-Yesil et al, 2018; Tinghög et al, 2017; Uygun, 2021; Woltin et al, 2018; Yalim, 2021). The most used instrument was the Hopkins Symptom Checklist 25-items (HSCL-25), and the prevalence of positive screening results ranged from 34.7% to 59.4%.…”